ACELRX PHARMACEUTICALS INC (43) | Uncategorized (7)
Recent Contracts
-
Form of CVR Agreement
(Filed With SEC on November 15, 2021)
-
Promotion Agreement among the Registrant, La Jolla Pharmaceutical Company and Tetraphase Pharmaceuticals, Inc., effective September 30, 2020
(Filed With SEC on November 5, 2020)
-
Form of Revised CVR Agreement
(Filed With SEC on May 29, 2020)
-
Amendment No. 1 to Co-Promotion Agreement, dated as of May 26, 2020, by and between the Registrant and Tetraphase
(Filed With SEC on May 29, 2020)
-
Form of Revised CVR Agreement
(Filed With SEC on May 27, 2020)
-
Agreement between the Registrant and SpecGX, LLC, dated June 16, 2017
(Filed With SEC on November 7, 2019)
-
Amendment to Agreement between the Registrant and SpecGX, LLC, dated September 23, 2019
(Filed With SEC on November 7, 2019)
